Advanced Cell Diagnostics Competitors

Every biological process leaves a biochemical signature. Genetics, disease, the microbiome, diet, lifestyle and environmental exposures all influence the biochemicals circulating through cells, tissues and biofluids. By measuring these small molecules at scale, metabolomics provides one of the closest views of biological function available. Metabolon is the global leader in metabolomics, delivering high-quality, large-scale biochemical profiling that helps researchers gain deeper insight into biology. From a single biological sample, our technology measures thousands of metabolites, providing a comprehensive snapshot of physiological state and revealing biological changes associated with disease, therapeutic intervention, nutrition and environmental factors. These insights help advance biomarker discovery, drug development, precision medicine and population health. Our scientific leadership is built on the world's largest metabolomics reference library, containing more than 5,400 known compounds, together with industry-leading analytical platforms and 26+ years of metabolomics expertise. This unique combination enables researchers to identify novel biology with confidence and generate reproducible, actionable data. Since our founding in 2000, Metabolon has supported more than 15,000 independent and collaborative studies, contributing to over 4,000 peer-reviewed publications. Headquartered in Research Triangle Park, North Carolina, we partner with pharmaceutical, biotechnology, academic, healthcare and nutrition organizations worldwide to accelerate scientific discovery and improve human health.

Biocept, Inc. (Nasdaq: BIOC) develops and performs clinical laboratory tests to help patients with cancer that has metastasized to the central nervous system (CNS). Our CNSide™ assay provides enhanced detection and analysis of tumor cells and cell-free DNA from cerebrospinal fluid (CSF). Quantitative results help evaluate a patient’s response to treatment. Additional biomarkers can characterize genetic changes associated with therapy resistance and identify new options for treating CNS metastasis. CNSide results from Biocept’s CLIA-certified and CAP-accredited laboratory help oncologists manage one of the most difficult complications of cancer, answering three critical questions: Is there tumor in the CSF? Is there a target for treatment? Is there a trend in treatment response? The Biocept team is dedicated to improving care for cancer patients – which means making a difference in people’s lives, every day. Biocept also provides RT-PCR based COVID-19 testing to support state and national public health efforts.

BioGenex designs, develops, and commercializes advanced fully-automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The recent introduction of our eFISHency integrated workflow solution for FISH laboratories and miRNA system for characterization of cancer of unknown primary (CUP) and for undifferentiated tumors is a game changer that has no rival in the industry. Our fully automated molecular pathology work stations are the most advanced system globally. Our customer focused approach, with premier after sales support and excellent technical service, provides the best in class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest systems for life science research and diagnostics. With a team of accomplished technical, business and customer support professionals, BioGenex strives to reach the pinnacle of the global molecular medicine industry by offering cost-effective solutions for life sciences research and personalized medicine. Additionally, the partnership of BioGenex with top-notch universities, hospitals, and the pharmaceutical and biotechnology industry drives its innovative research and product development activities. The company is also known for its pre- and post-sales customer support that complements the high quality products and solutions offered by the firm.